CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells

Alessia Grozio; Giovanna Sociali; Laura Sturla; Irene Caffa; Debora Soncini; Annalisa Salis; Nadia Raffaelli; Antonio De Flora; Alessio Nencioni; Santina Bruzzone

doi:10.1074/jbc.M113.470435

CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells

Alessia Grozio, Giovanna Sociali, Laura Sturla, Irene Caffa, Debora Soncini, Annalisa Salis, Nadia Raffaelli, Antonio De Flora, Alessio Nencioni, Santina Bruzzone

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Contribution to journal › Article

Abstract

Background: NAMPT inhibitors showed antitumor activity in preclinical cancer models, but no tumor remission occurred in clinical studies. Results: Cells treated with a NAMPT inhibitor are rescued by low NAD+ e or NAD+ precursors, depending on CD38 and CD73 expression. Conclusion: CD73 enables, whereas CD38 impairs, extracellular NMN utilization by cells for NAD+ biosynthesis. Significance: Combining CD73 and NAMPT inhibition could represent a new anti-cancer strategy.

Original language	English
Pages (from-to)	25938-25949
Number of pages	12
Journal	Journal of Biological Chemistry
Volume	288
Issue number	36
DOIs	https://doi.org/10.1074/jbc.M113.470435
Publication status	Published - Sep 6 2013

Fingerprint

ASJC Scopus subject areas

Biochemistry
Cell Biology
Molecular Biology

Cite this

Grozio, A., Sociali, G., Sturla, L., Caffa, I., Soncini, D., Salis, A., Raffaelli, N., De Flora, A., Nencioni, A., & Bruzzone, S. (2013). CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells. Journal of Biological Chemistry, 288(36), 25938-25949. https://doi.org/10.1074/jbc.M113.470435

CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells. / Grozio, Alessia; Sociali, Giovanna; Sturla, Laura; Caffa, Irene; Soncini, Debora; Salis, Annalisa; Raffaelli, Nadia; De Flora, Antonio; Nencioni, Alessio; Bruzzone, Santina.

In: Journal of Biological Chemistry, Vol. 288, No. 36, 06.09.2013, p. 25938-25949.

Research output: Contribution to journal › Article

Grozio, Alessia ; Sociali, Giovanna ; Sturla, Laura ; Caffa, Irene ; Soncini, Debora ; Salis, Annalisa ; Raffaelli, Nadia ; De Flora, Antonio ; Nencioni, Alessio ; Bruzzone, Santina. / CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells. In: Journal of Biological Chemistry. 2013 ; Vol. 288, No. 36. pp. 25938-25949.

@article{61e6a5fc358845b89f40f7891a20148d,

title = "CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells",

abstract = "Background: NAMPT inhibitors showed antitumor activity in preclinical cancer models, but no tumor remission occurred in clinical studies. Results: Cells treated with a NAMPT inhibitor are rescued by low NAD+ e or NAD+ precursors, depending on CD38 and CD73 expression. Conclusion: CD73 enables, whereas CD38 impairs, extracellular NMN utilization by cells for NAD+ biosynthesis. Significance: Combining CD73 and NAMPT inhibition could represent a new anti-cancer strategy.",

author = "Alessia Grozio and Giovanna Sociali and Laura Sturla and Irene Caffa and Debora Soncini and Annalisa Salis and Nadia Raffaelli and {De Flora}, Antonio and Alessio Nencioni and Santina Bruzzone",

year = "2013",

month = sep

day = "6",

doi = "10.1074/jbc.M113.470435",

language = "English",

volume = "288",

pages = "25938--25949",

journal = "Journal of Biological Chemistry",

issn = "0021-9258",

publisher = "American Society for Biochemistry and Molecular Biology Inc.",

number = "36",

}

TY - JOUR

T1 - CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells

AU - Grozio, Alessia

AU - Sociali, Giovanna

AU - Sturla, Laura

AU - Caffa, Irene

AU - Soncini, Debora

AU - Salis, Annalisa

AU - Raffaelli, Nadia

AU - De Flora, Antonio

AU - Nencioni, Alessio

AU - Bruzzone, Santina

PY - 2013/9/6

Y1 - 2013/9/6

N2 - Background: NAMPT inhibitors showed antitumor activity in preclinical cancer models, but no tumor remission occurred in clinical studies. Results: Cells treated with a NAMPT inhibitor are rescued by low NAD+ e or NAD+ precursors, depending on CD38 and CD73 expression. Conclusion: CD73 enables, whereas CD38 impairs, extracellular NMN utilization by cells for NAD+ biosynthesis. Significance: Combining CD73 and NAMPT inhibition could represent a new anti-cancer strategy.

AB - Background: NAMPT inhibitors showed antitumor activity in preclinical cancer models, but no tumor remission occurred in clinical studies. Results: Cells treated with a NAMPT inhibitor are rescued by low NAD+ e or NAD+ precursors, depending on CD38 and CD73 expression. Conclusion: CD73 enables, whereas CD38 impairs, extracellular NMN utilization by cells for NAD+ biosynthesis. Significance: Combining CD73 and NAMPT inhibition could represent a new anti-cancer strategy.

UR - http://www.scopus.com/inward/record.url?scp=84883738070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883738070&partnerID=8YFLogxK

U2 - 10.1074/jbc.M113.470435

DO - 10.1074/jbc.M113.470435

M3 - Article

C2 - 23880765

AN - SCOPUS:84883738070

VL - 288

SP - 25938

EP - 25949

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 36

ER -

Access to Document

10.1074/jbc.M113.470435